قيمة العلامة المصلية اختيار مصل رباط محفز التكاثر نوع A في تشخيص سرطان القولون في المرضى العراقيين == The value of serological marker serum A proliferation Inducing Ligand test in the Diagnosis of colon cancer in Iraqi patients
Author name:
عقيل حاتم محمود
Supervisor name:
سرمد محمد حسين الزيني | عقيل شاكر محمود
General topic:
Medicine
Specific topic:
Microbiology
Degree:
Master
University:
University of Baghdad - Faculty Of Medicine
Language:
English
University location:
Baghdad
First pages:
19T1420 - p.pdf
Abstract:
Colonic cancer is a very common disease world - wide being fourth most common cancer characterized by abnormal proliferation of the epithelium of colon at beginning then taking full colon wall thickness then to surrounding lymph nodes and tissues and finally metastasis. It is one of most complicated diseases with debilitating symptoms which becomes more severe, prominent and specific with advancing stage with high percent of fatality and relatively short survival if diagnosed late or if left untreated.Therefore, finding an easy, non - invasive and readily available means (marker) of diagnosing colonic cancer would be of great value particularly if the same biomarker can be used for diagnosis, screening, prognosis and monitoring the efficacy of different treatment modalities.Study objectives : - To investigate the efficacy and validity of serum Carcinoembryonic Antigen (CEA) and serum A Proliferation inducing Ligand (sAPRIL) levels in the diagnosis of colon cancer as individual and as combined tests. Analyze the case - control differences in serum CEA and APRIL. Evaluate the diagnostic performance of serum CEA and APRIL and their combination in predicting colon cancer and Assess the association between the two markers. Suggest an optimum cut - off value for these two serum markers. Evaluate the effect of age, gender, tumor stage, alcohol and smoking habits, chemotherapy, surgical excision and immunotherapy on serum CEA and APRIL in cases with colon cancer. Patients and methods : - This study was applied on 35 patients (14 females & 21 males) withcolon cancer with ages ranged 58 - 88 years old (9 patients receivedchemotherapy and all of them have undergone surgical removal of the primarytumor and 4 different patients received immunotherapy which is monoclonalantibody) with 15 smokers and 7 alcoholic, 35 patients (19 females & 16 males)with benign polyps ages ranged 30 - 56 years old and 15 (7 females & 8 males)negative controls ages ranged 25 - 37 years age, samples were collected in theperiod between October 2016 and July 2017.According to DUKE's staging which is determined according histopathology after colonoscopy and few from surgery : 4 colon cancer patients were stage A, 9 were stage B, 12 were stage C and 10 were stage D.All individuals in this study (whom attended Baghdad Teaching Hospital and Gastroenterology and Hepatology teaching hospital) were subjected to blood sampling for measuring their serum CEA and sAPRIL using Enzyme Linked ImmunoSorbent Assay (ELISA) technique which was done at microbiology unit / university of Baghdad.Results : - The present study has shown that colonic cancer patients were presented at ages between 58 - 88 years of age ( 69 ± 8.2 years of age).Serum levels of CEA & sAPRIL were significantly elevated in those patients with advancing stages (C & D) compared with stages (A & B) and lower levels found in patients who had surgical removal of tumor or received chemotherapy.Also a positive relation found between CEA & sAPRIL from hand with alcohol intake & smoking on the other hand.
